Skip to content

Study of efficacy of peripheral nerve blocks in lumbar disc herniation pain

Effectiveness of peripheral nerve blocks in acute radicular pain due to lumbar intervertebral disc herniation and its effect on inflammatory cytokines: A prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036406
Enrollment
29
Registered
2021-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Peripheral Nerve Blocks according to involvement of nerves: Patient will receive peripheral nerve blocks according to their involvement of nerve roots, in the OPD treatment room, with f

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18-50 years of both sexes. 2.History of segmental low back pain of lumbar (L5) or sacral (S1) origin with radiation to unilateral lower limb below knee of less than 1-month duration. 3.Patients who are not the candidates for surgery. 4.Average pain score of >=4 on an 11-point NRS. 5.Tenderness over the concordant peripheral nerves (Gore sign +) 6.Magnetic resonance imaging (MRI) evidence of nerve root pain concordant with the side and level of clinical features.

Exclusion criteria

Exclusion criteria: 1.Coagulopathy and/or patients on anticoagulants. 2.Infection at the site of injection. 3.Hypersensitivity to local anesthetic agent. 4.Evidence of significant progressive sensory or motor deficit, cauda-equina syndrome, H/O trauma, infection and cancer (Red flag signs). 5.Evidence of severe psychiatric illness. 6.History of previous backs surgery/epidural steroid injection. 7.History of any major comorbid medical conditions, those interfere with recording of study outcomes (any auto-immune diseases), multiple sclerosis, and pregnancy.

Design outcomes

Primary

MeasureTime frame
1.Pain relief as assessed by Numerical Rating Scale (NRS) on a scale of 1-10 immediately after the procedure, at 2 weeks and at 2 and 3 months after the procedureTimepoint: 1.Pain relief as assessed by Numerical Rating Scale (NRS) on a scale of 1-10 immediately after the procedure, at 2 weeks and at 2 and 3 months after the procedure

Secondary

MeasureTime frame
1.Changes in biomarkers of pain before and after distal nerve block (high sensitive C reactive protein, tumor necrosis factor-alpha, interleukin 6, interleukin-4) 2.Physical functioning as assessed by Roland Morris Questionnaire (Annexure â??II) 3.Global Perceived Effects (Annexure-III) 4.To assess spontaneous reporting of adverse effects and the incidence of complications due to the procedure. Timepoint: Changes in biomarkers of pain before and after distal nerve block

Countries

India

Contacts

Public ContactDr Praveen Talawar

All India Institute of Medical Sciences, Rishikesh

praveenrt64@gmail.com9654162941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026